These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3132332)

  • 21. [Intracavitary treatment of tumors of the bladder with cytotoxic agent (mitomycin C) and radioactive phosphorus (32P). II].
    Ogawa H
    Nihon Hinyokika Gakkai Zasshi; 1969 Aug; 60(8):724-7. PubMed ID: 5388927
    [No Abstract]   [Full Text] [Related]  

  • 22. [Intraarterial infusion therapy with polysaccharide solution as a carrier of anticancer drugs].
    Sako M; Shimizu T; Hirota S; Ohtsuki S; Hasegawa M; Watanabe H; Okuda K; Hase M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Sep; 45(9):1278-80. PubMed ID: 3005964
    [No Abstract]   [Full Text] [Related]  

  • 23. [Study of regional perfusion of the extremities using the antineoplastic agent mitomycin-C].
    Watanabe S
    Nihon Seikeigeka Gakkai Zasshi; 1966 Jan; 39(10):987-1002. PubMed ID: 5212511
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of (+)-cyclaradine-5'-esters as prodrugs for (+)-cyclaradine in animals.
    Lim J; Schwartz J; Loebenberg D; Miller GH; Symchowicz S; Lin C
    Antimicrob Agents Chemother; 1987 Jul; 31(7):998-1001. PubMed ID: 3662479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular interaction and in vitro antitumor effect of various mitomycin C prodrugs in mitomycin C-resistant L1210 leukemia cell lines.
    Matsumoto S; Shigeoka T; Takakura Y; Hashida M; Sezaki H
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3792-9. PubMed ID: 3124967
    [No Abstract]   [Full Text] [Related]  

  • 26. Production of a monoclonal antibody-mitomycin C conjugate, utilizing dextran T-40, and its biological activity.
    Manabe Y; Tsubota T; Haruta Y; Kataoka K; Okazaki M; Haisa S; Nakamura K; Kimura I
    Biochem Pharmacol; 1985 Jan; 34(2):289-91. PubMed ID: 2578281
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on pharmaceutical modification of anticancer agents. I. Enhancement of lymphatic transport of mitomycin C by parenteral emulsions.
    Nakamoto Y; Fujiwara M; Noguchi T; Kimura T; Muranishi S; Sezaki H
    Chem Pharm Bull (Tokyo); 1975 Oct; 23(10):2232-8. PubMed ID: 1212753
    [No Abstract]   [Full Text] [Related]  

  • 28. [Studies on the enhancing action of isoproterenol on the metabolism of mitomycin C].
    Matsunaga T; Miyamoto K; Wakusawa S; Koshiura R
    Yakugaku Zasshi; 1986 Nov; 106(11):1057-63. PubMed ID: 3104575
    [No Abstract]   [Full Text] [Related]  

  • 29. A novel strategy for ADME screening of prodrugs: combined use of serum and hepatocytes to integrate bioactivation and clearance, and predict exposure to both active and prodrug to the systemic circulation.
    Hoppe E; Hewitt NJ; Buchstaller HP; Eggenweiler HM; Sirrenberg C; Zimmermann A; März J; Schwartz H; Saal C; Meyring M; Hecht S
    J Pharm Sci; 2014 May; 103(5):1504-14. PubMed ID: 24648352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Topical application of mitomycin C conjugated with dextran (MMC-D): a high molecular weight derivative of mitomycin C].
    Honda K; Satomura K; Hashida M; Sezaki H
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):530-5. PubMed ID: 2408576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modification of deoxyribonucleic acid with reductively activated mitomycin C. Structures of modified nucleotides.
    Hashimoto Y; Shudo K; Okamoto T
    Chem Pharm Bull (Tokyo); 1983 Mar; 31(3):861-9. PubMed ID: 6411371
    [No Abstract]   [Full Text] [Related]  

  • 32. High-performance liquid chromatographic determination of mitomycin C in rat and human plasma and urine.
    Dalton JT; Geuns ER; Au JL
    J Chromatogr; 1989 Oct; 495():330-7. PubMed ID: 2515201
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmacokinetics of mitomycin C and its derivative (KW-2083)].
    Fujita H
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1362-73. PubMed ID: 6820913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biliary and pancreatic excretion of mitomycin C, with special reference to the concomitant use of urokinase].
    Suda Y; Sekine T
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2225-6. PubMed ID: 3933436
    [No Abstract]   [Full Text] [Related]  

  • 35. Cellular interaction and in vitro antitumor activity of lipophilic mitomycin C prodrugs.
    Matsumoto S; Hayashi Y; Hashida M; Sezaki H
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3784-91. PubMed ID: 3124966
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effects of mitomycin C perfusion after bladder tumor surgery].
    Zhou CL
    Zhonghua Wai Ke Za Zhi; 1989 Nov; 27(11):654-5, 700. PubMed ID: 2517250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prodrug approaches to reduce hyperexcitation in the CNS.
    Vytla D; Combs-Bachmann RE; Hussey AM; McCarron ST; McCarthy DS; Chambers JJ
    Adv Drug Deliv Rev; 2012 May; 64(7):666-85. PubMed ID: 22138074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies of mitomycin C absorption after intravesical treatment of superficial bladder tumors.
    Wajsman Z; Dhafir RA; Pfeffer M; MacDonald S; Block A; Dragone N; Pontes JE
    J Urol; 1984 Jul; 132(1):30-3. PubMed ID: 6427484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circumvention of deficient activation in mitomycin C-resistant human colonic carcinoma cells by the mitomycin C analogue BMY25282.
    Chakrabarty S; Danels YJ; Long BH; Willson JK; Brattain MG
    Cancer Res; 1986 Jul; 46(7):3456-8. PubMed ID: 3754788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [An approach to magnetically controlled cancer chemotherapy. V. Preparation, properties and pharmacokinetics of microcapsules encased with magnetic particles and mitomycin C (author's transl)].
    Kato T; Nemoto R; Mori H; Abe R; Unno K; Goto A; Murota H; Harada M; Kawamura K; Homma M
    Nihon Gan Chiryo Gakkai Shi; 1981 Dec; 16(7):1351-7. PubMed ID: 7341711
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.